Literature DB >> 3040549

Adrenergic receptors in inner and outer layers of human myometrium near term: characterization of beta-adrenergic receptor sites by [125I]-iodocyanopindolol binding.

M Breuiller, B Rouot, M J Leroy, P Blot, L Kaplan, F Ferré.   

Abstract

The beta-adrenergic receptors present in inner and outer layers of human myometrium near term were characterized using the radioiodinated antagonist iodocyanopindolol (ICYP). In both layers ICYP binding is saturable, rapidly reversible, stereoselective, and appears to occur in a single class of sites with a KD of 30 pmol/l. Adrenergic agonists compete for ICYP binding sites with an order of potency consistent with beta 2-adrenergic potencies: isoproterenol greater than epinephrine much greater than norepinephrine. Studies in which CGP 20712 A, a beta 1-adrenergic antagonist, competes for ICYP binding sites in human myometrium reveal that at least 65% of the beta-receptors present are beta 2-subtype, whatever the layer considered. At the 35th week of pregnancy, the density of beta-adrenergic receptors in the inner layer (15.2 fmol/mg of protein) is about 50% higher than in the outer layer. At term, the densities of beta-adrenergic receptors are reduced and exhibit the same values for both layers (5 fmol/mg of protein). These results indicate that the beta-adrenergic receptors in the two layers diminish during pregnancy and reach, at term, an equal and low level of density.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040549     DOI: 10.1159/000298771

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  5 in total

Review 1.  Hormonal and local regulation of uterine activity during parturition: Part II--The prostaglandin and adrenergic systems.

Authors:  M Maggi; E Baldi; T Susini
Journal:  J Endocrinol Invest       Date:  1994-10       Impact factor: 4.256

2.  The human near-term myometrial beta 3-adrenoceptor but not the beta 2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation.

Authors:  C Rouget; M Breuiller-Fouché; F J Mercier; M J Leroy; C Loustalot; E Naline; R Frydman; T Croci; E J Morcillo; C Advenier; M Bardou
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

3.  Lymphocyte beta 2-adrenoceptors and adenosine 3':5'-cyclic monophosphate during and after normal pregnancy.

Authors:  U von Mandach; H P Gubler; G Engel; R Huch; A Huch
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

4.  The Inhibitory Effect of Haloxylon salicornicum on Contraction of the Mouse Uterus.

Authors:  Nabila H Saleem; Valerie A Ferro; Ann M Simpson; John Igoli; Alexander I Gray; Robert M Drummond
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

Review 5.  Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?

Authors:  Marc Bardou; Céline Rouget; Michèle Breuiller-Fouché; Catherine Loustalot; Emmanuel Naline; Paul Sagot; René Frydman; Esteban J Morcillo; Charles Advenier; Marie-Josèphe Leroy; John J Morrison
Journal:  BMC Pregnancy Childbirth       Date:  2007-06-01       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.